Overview
Osamu Hiranuma practices in Otsu, Japan. Mr. Hiranuma is highly rated in 2 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Hypersensitivity Vasculitis.
His clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMr. Hiranuma isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Hiranuma isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Experienced
- EGFR Positive Lung CancerMr. Hiranuma isExperienced. Learn about EGFR Positive Lung Cancer.
- Hypersensitivity VasculitisMr. Hiranuma isExperienced. Learn about Hypersensitivity Vasculitis.
- Mycobacterium Avium Complex InfectionsMr. Hiranuma isExperienced. Learn about Mycobacterium Avium Complex Infections.
- Pleural EffusionMr. Hiranuma isExperienced. Learn about Pleural Effusion.
- Small Cell Lung Cancer (SCLC)Mr. Hiranuma isExperienced. Learn about Small Cell Lung Cancer (SCLC).